8-K 1 d86635e8-k.txt FORM 8-K 1 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K -------------------------------------------------------------------------------- CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 1, 2001 AMEDISYS, INC. -------------- (Exact Name of Registrant as Specified in Charter) Delaware -------- (State or Other Jurisdiction of Incorporation or Organization) 0-24260 11-3131700 -------- ---------- (Commission File Number) (I.R.S. Employer Identification No.) 11100 Mead Road, Suite 300, Baton Rouge, LA 70816 ------------------------------------------------- (Address of principal executive offices including zip code) (225) 292-2031 -------------- (Registrant's telephone number, including area code) 2 ITEM 5. OTHER EVENTS On May 1, 2001, Amedisys, Inc., "the Company", issued a press release attached hereto as Exhibit 99.1 to announce quarter ended March 31, 2001 operating results. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (a) Financial Statements of Business Acquired. Not applicable. (b) Pro Forma Financial Information. Not applicable. (c) Exhibit No. Page ------- ---- 99.1(i) Press Release dated May 1, 2001 announcing quarter ended March 31, 2001 operating results....A-1 (i) Filed herewith. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMEDISYS, INC. By: /s/ John M. Joffrion ------------------------------------------ John M. Joffrion Senior Vice President of Finance Principal Accounting and Financial Officer DATE: May 1, 2001 3 EXHIBIT INDEX
EXHIBIT NUMBER DESCRIPTION ------ ----------- 99.1(i) Press Release dated May 1, 2001 announcing quarter ended March 31, 2001 operating results
(i) Filed herewith.